Weightloss peptide Tirzepatide Retatrutide AOD NAD BPC TB 5mg 10mg peptide vials...
TDS 1 Inquiries
566-78-9
Pharmaceutical Grade
99%
Hong Kong
customizable
10vials/box
2027-12-25
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
21-Acetoxypregnenolone
Other Name:Pregn-5-en-20-one,21-(acetyloxy)-3-hydroxy-,(3β)-;Pregn-5-en-20-one,3β,21-dihydroxy-,21-acetate;(3β)-21-(Acetyloxy)-3-hydroxypregn-5-en-20-one;Acetoxanon;21-Acetoxy-5-pregnen-3-ol-20-one;Artisone acetate;Prebediolone acetate;3β-Hydroxy-21-acetoxypregn-5-en-20-one;5-Pregnene-3β,21-diol-20-one 21-acetate;21-Acetoxypregnenolone;3-Hydroxy-21-acetoxy-5-pregnen-20-one;21-Acetoxy-3β-hydroxypregn-5-en-20-one;Pregnenolone 21-acetate;Artisone;Artixone acetate;NSC 66372
CAS No.:566-78-9
Molecular Formula:C23H34O4
InChIKeys:InChIKey=MDJRZSNPHZEMJH-MTMZYOSNSA-N
Molecular Weight:374.51
Exact Mass:374.51
EC Number:209-298-9
Categories:
Characteristics-
PSA:
63.60000
XLogP3:4.05850
Density:1.15g/cm3
Melting Point:184.5 °C
Boiling Point:500.2ºC at 760mmHg
Flash Point:166.6ºC
Refractive Index:1.549
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Survodutide,GHK-CU,GLOW,KLOW
-
Location:
Building 1, Floor 2, No. 96 Banhe Road, Huangpu District, Guangzhou City, Room 2164
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
12
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
Certifications:
COA,COA,COA,COA,COA,COA,COA,COA,COA
"> -
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Russia
Weightloss peptide Tirzepatide Retatrutide AOD NAD BPC TB 5mg 10mg peptide vials
196 MT Jun 24, 2026 Post an enquiry for this product
